Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of intrathecal 2-chloroprocaine 1% for short lower limb surgery in adolescents
ISRCTN57987506Phase 2Terminated
- Sponsor
- Sintetica
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of chloroprocaine (3 arms), sponsored by Sintetica. Primary endpoint: Need for additional analgesia or rescue general anesthesia during surgery. Started Mar 2011; status: terminated.
02
Drugs
chloroprocaine
Beyond the preview
Go deeper on ISRCTN57987506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN57987506.